title: Poly(ethylene glycol) hydrogels formed by thiol-ene photopolymerization for enzyme-responsive protein delivery.
abstract: Degradable hydrogels have been extensively used in biomedical applications such as drug delivery, and recent interest has grown in hydrogels that degrade in recognition of a cellular response. This contribution describes a poly(ethylene glycol) (PEG) hydrogel platform with human neutrophil elastase (HNE) sensitive peptide cross-links formed using thiol-ene photopolymerization rendering the gel degradable at sites of inflammation. Further, protein therapeutics can be physically entrapped within the network and selectively released upon exposure to HNE. HNE-responsive hydrogels exhibited surface erosion where the degradation kinetics was influenced by changes in peptide k(cat), concentration of HNE, and concentration of peptide within the gel. Using this platform, we were able to achieve controlled, zero-order release of bovine serum albumin (BSA) in the presence of HNE, and release was arrested in the absence of HNE. To further exploit the advantages of surface eroding delivery systems, a smaller protein (carbonic anhydrase) was delivered at the same rate as BSA and only dependent on gel formulation and environmental conditions. Also, protein release was predicted from a 3-layered hydrogel device using mass loss data. Lastly, the bioactivity of lysozyme was maintained above 90% following the exposure to thiol-ene photopolymerization conditions.
authors.affiliation: Department of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309, USA.
authors.forename: Alex A
authors.initials: AA
authors.lastname: Aimetti
authors.forename: Alexandra J
authors.initials: AJ
authors.lastname: Machen
authors.forename: Kristi S
authors.initials: KS
authors.lastname: Anseth
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry*; D002417:Cattle; D016503:Drug Delivery Systems; D004798:Enzymes / Q000737:chemistry*; D006801:Humans; D020100:Hydrogels / Q000737:chemistry*; D007249:Inflammation; D007700:Kinetics; D019272:Leukocyte Elastase / Q000737:chemistry; D008027:Light; D009113:Muramidase / Q000737:chemistry; D011092:Polyethylene Glycols / Q000737:chemistry*; D011506:Proteins / Q000008:administration & dosage* / Q000737:chemistry; D012709:Serum Albumin / Q000737:chemistry; D013438:Sulfhydryl Compounds / Q000737:chemistry*; D013499:Surface Properties
chemical_list: D001672:Biocompatible Materials; D004798:Enzymes; D020100:Hydrogels; D011506:Proteins; D012709:Serum Albumin; D013438:Sulfhydryl Compounds; D011092:Polyethylene Glycols; D009113:Muramidase; D019272:Leukocyte Elastase
references.citation: Biomaterials. 2000 Dec;21(23):2395-404
references.pmid: 11055287
references.citation: FASEB J. 2001 May;15(7):1300-2
references.pmid: 11344120
references.citation: J Control Release. 2001 May 14;72(1-3):101-13
references.pmid: 11389989
references.citation: Eur J Pharm Biopharm. 2000 Jul;50(1):27-46
references.pmid: 10840191
references.citation: J Control Release. 2001 Jun 15;73(2-3):233-44
references.pmid: 11516501
references.citation: Jpn J Physiol. 1999 Feb;49(1):27-33
references.pmid: 10219106
references.citation: Adv Drug Deliv Rev. 2002 Jun 17;54(4):505-30
references.pmid: 12052712
references.citation: J Control Release. 2001 Sep 11;76(1-2):11-25
references.pmid: 11532309
references.citation: J Biomed Mater Res. 1999 Aug;46(2):271-8
references.pmid: 10380006
references.citation: J Control Release. 2004 Jun 18;97(2):333-43
references.pmid: 15196760
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5413-8
references.pmid: 12686696
references.citation: Biomaterials. 2001 May;22(9):929-41
references.pmid: 11311012
references.citation: Biomacromolecules. 2009 Jun 8;10(6):1484-9
references.pmid: 19408953
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16242-7
references.pmid: 18852471
references.citation: Biomaterials. 1996 Sep;17(17):1647-57
references.pmid: 8866026
references.citation: Adv Drug Deliv Rev. 1998 May 4;31(3):197-221
references.pmid: 10837626
references.citation: Nat Rev Mol Cell Biol. 2008 Aug;9(8):628-38
references.pmid: 18628784
references.citation: N Engl J Med. 2001 Mar 22;344(12):907-16
references.pmid: 11259725
references.citation: J Biomed Mater Res. 1989 Oct;23(10):1183-93
references.pmid: 2808463
references.citation: Bioconjug Chem. 2001 Mar-Apr;12(2):195-202
references.pmid: 11312680
references.citation: Biomaterials. 2002 Nov;23(22):4315-23
references.pmid: 12219821
references.citation: Biomaterials. 2001 Nov;22(22):3045-51
references.pmid: 11575479
references.citation: Pharm Res. 2006 Mar;23(3):614-22
references.pmid: 16397740
references.citation: Adv Mater. 2009 Dec 28;21(48):5005-5010
references.pmid: 25377720
references.citation: Adv Drug Deliv Rev. 2001 Dec 31;53(3):321-39
references.pmid: 11744175
references.citation: Biomaterials. 2002 Nov;23(22):4307-14
references.pmid: 12219820
references.citation: Adv Drug Deliv Rev. 2006 Nov 30;58(12-13):1379-408
references.pmid: 17081649
references.citation: Biotechnol Bioeng. 2004 Jun 30;86(7):747-55
references.pmid: 15162450
references.citation: Biomacromolecules. 2008 Jan;9(1):75-83
references.pmid: 18088094